Pure Global AI
ANVISA registration 80146502386Valid until Sep 04, 2033

SELF-TEST FOR GLUCOSE MONITORING IN INTERSTITIAL FLUID (PERCUTANEOUS) - SENSOR/TRANSMITTER

ANVISA Registration Number: 80146502386ABBOTT LABORATORIOS DO BRASIL LTDAABBOTT DIABETES CARE LTDRisk Class III
Device names
Technical name
SELF-TEST FOR GLUCOSE MONITORING IN INTERSTITIAL FLUID (PERCUTANEOUS) - SENSOR/TRANSMITTER
PT: AUTOTESTE PARA MONITORAMENTO DA GLICOSE EM LÍQUIDO INTERSTICIAL (PERCUTÂNEO) - SENSOR/TRANSMISSOR
Commercial name
FreeStyle Libre 2 Plus Sistema Flash de Monitoramento de Glicose - Sensor
Risk class
Class III
Registration details
Registration Number
80146502386
Process Number
25351158859202352
CNPJ
56998701000116
Company information
Manufacturing Country
United Kingdom
PT: REINO UNIDO
Dates and status
Publication Date
Sep 04, 2023
Validity
04/09/2033
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for SELF-TEST FOR GLUCOSE MONITORING IN INTERSTITIAL FLUID (PERCUTANEOUS) - SENSOR/TRANSMITTER in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80146502386 and manufactured by ABBOTT DIABETES CARE LTD. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until Sep 04, 2033.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.